On August 27, 2026, Aimed Alliance submitted feedback on Senator Cassidy’s 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft, which aims to strengthen the 340B Program to better serve vulnerable patients and families.
Aimed Alliance’s comment supports the draft’s provisions proposed codification of a statutory definition of a 340B patient, strengthening contract pharmacy oversight, establishing a clear patient definition, and improving transparency and accountability within the program. Aimed Alliance also supported stronger audit and eligibility requirements, while urging Congress to ensure the Act preserves patient access. Read Aimed Alliance’s response to the discussion draft feedback.
